A detailed history of Readystate Asset Management LP transactions in Catalent, Inc. stock. As of the latest transaction made, Readystate Asset Management LP holds 188,154 shares of CTLT stock, worth $11.9 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
188,154
Holding current value
$11.9 Million
% of portfolio
0.21%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$56.16 - $60.96 $10.6 Million - $11.5 Million
188,154 New
188,154 $11.4 Billion
Q4 2023

Feb 14, 2024

BUY
$32.18 - $46.57 $1.08 Million - $1.56 Million
33,558 Added 52.71%
97,223 $4.37 Billion
Q3 2023

Nov 14, 2023

SELL
$44.2 - $50.2 $367,169 - $417,011
-8,307 Reduced 11.54%
63,665 $2.9 Billion
Q2 2023

Aug 14, 2023

BUY
$31.86 - $67.26 $938,500 - $1.98 Million
29,457 Added 69.29%
71,972 $3.12 Billion
Q1 2023

May 15, 2023

BUY
$45.44 - $74.26 $1.93 Million - $3.16 Million
42,515 New
42,515 $2.79 Billion

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Readystate Asset Management LP Portfolio

Follow Readystate Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Readystate Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Readystate Asset Management LP with notifications on news.